Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults

S. Silberstein, P. Tfelt-Hansen, D.W. Dodick, V. Limmroth, R.B. Lipton, J. Pascual, S.J. Wang

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

276 Citationer (Scopus)

Abstract

In 1991 the Clinical Trials Subcommittee of the International Headache Society (IHS) developed and published its first edition of the Guidelines on controlled trials of drugs in episodic migraine because only quality trials can form the basis for international collaboration on drug therapy, and these Guidelines would 'improve the quality of controlled clinical trials in migraine'. With the current trend for large multinational trials, there is a need for increased awareness of methodological issues in clinical trials of drugs and other treatments for chronic migraine. These Guidelines are intended to assist in the design of well-controlled clinical trials of chronic migraine in adults, and do not apply to studies in children or adolescents
Udgivelsesdato: 2008/5
OriginalsprogEngelsk
TidsskriftCephalalgia
Vol/bind28
Udgave nummer5
Sider (fra-til)484-495
Antal sider11
ISSN0333-1024
StatusUdgivet - 2008

Bibliografisk note

Times Cited: 2ReviewEnglishSilberstein, SThomas Jefferson Univ Hosp, Jefferson Headache Ctr, 111 S 11th St,Suite 8130, Philadelphia, PA 19107 USACited References Count: 42285PSBLACKWELL PUBLISHING9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLANDOXFORD

Citationsformater